OncoC4 Secures $50 Million in Series B Funding for Cancer Therapy Development
OncoC4 has closed a Series B financing round of nearly $50 million, announced in a press release. The round was led by GBA Fund, with participation from the company's co-founders and existing investors, including HM Capital, 3E Bioventures Capital, and Kaitai Capital.
Founded in 2020 by immunologists Dr. Yang Liu and Dr. Pan Zheng, OncoC4 is focused on developing innovative therapies for cancer and neurodegenerative diseases. The funds from this financing round will be used to advance the clinical development of the company's pipeline programs, which target both novel and well-validated targets across oncology and immunological diseases.
Dr. Yang Liu, Co-Founder and CEO of OncoC4, expressed gratitude for the investors' support and emphasized the company's commitment to advancing its core pipeline and expanding business development activities globally.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 19 Knit Health raises $35 million to roll out its healthcare world model Nov 19 Banner Health invests in Layer Health and moves its clinical registries onto its AI platform Nov 19 Half of Koreans who changed medication on AI advice had side effects, survey finds Nov 19 Isomorphic Labs and MSD team up to design cancer drugs with AI Nov 19 Boltz raises $110 million to build AI models for drug designMore from Funding
Nov 20 hackajob raises $10 million to expand Archer, its AI recruiting agent Nov 20 Protesters rally against Anthropic in New York and San Francisco on its stock market debut Nov 19 Anthropic's IPO could channel about $156 billion to charity, TechCrunch estimates Nov 19 Sierra reportedly in talks to raise at a $30 billion valuation Nov 19 Everful raises $48.5 million to build AI infrastructure for global commerceAI Funding Brief
Humanoid Robot Makers
Companies building humanoid robots, from startups to Tesla and Boston Dynamics
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Pathos AI Raises $237 Million at $3 Billion Valuation
Formation Bio Forms $600 Million Drug Development Fund
ALLOX Raises $10.5 Million for AI Drug Discovery Platform
Stage 2 Capital Closes $100 Million for B2B AI Investments
Hone Health raises $228 million to expand AI-enabled longevity care
Daily AI Brief: the AI news that matters, in your inbox.